These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15560978)

  • 1. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
    Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
    Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs.
    Tabrizi CA; Walcher P; Mayr UB; Stiedl T; Binder M; McGrath J; Lubitz W
    Curr Opin Biotechnol; 2004 Dec; 15(6):530-7. PubMed ID: 15560979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virosomes as a vaccine adjuvant and carrier system.
    Moser C; Amacker M; Zurbriggen R
    Expert Rev Vaccines; 2011 Apr; 10(4):437-46. PubMed ID: 21506642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virosome concept for influenza vaccines.
    Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
    Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.
    Moser C; Amacker M; Kammer AR; Rasi S; Westerfeld N; Zurbriggen R
    Expert Rev Vaccines; 2007 Oct; 6(5):711-21. PubMed ID: 17931152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particulate delivery systems for animal vaccines.
    Scheerlinck JP; Greenwood DL
    Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
    Badiee A; Heravi Shargh V; Khamesipour A; Jaafari MR
    Vaccine; 2013 Jan; 31(5):735-49. PubMed ID: 23219436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
    Cryz SJ; Glück R
    Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virosomal adjuvanted antigen delivery systems.
    Moser C; Metcalfe IC; Viret JF
    Expert Rev Vaccines; 2003 Apr; 2(2):189-96. PubMed ID: 12899570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Rosenkrands I; Lindenstrøm T; Andersen P; Agger EM
    Expert Rev Vaccines; 2007 Oct; 6(5):785-96. PubMed ID: 17931158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.
    Schumacher R; Amacker M; Neuhaus D; Rosenthal R; Groeper C; Heberer M; Spagnoli GC; Zurbriggen R; Adamina M
    Vaccine; 2005 Dec; 23(48-49):5572-82. PubMed ID: 16165256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virosomes: a flu jab for malaria?
    Cavanagh DR; Remarque EJ; Sauerwein RW; Hermsen CC; Luty AJ
    Trends Parasitol; 2008 Sep; 24(9):382-5. PubMed ID: 18684667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant and antigen delivery properties of virosomes.
    Glück R; Burri KG; Metcalfe I
    Curr Drug Deliv; 2005 Oct; 2(4):395-400. PubMed ID: 16305442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
    Bungener L; Huckriede A; de Mare A; de Vries-Idema J; Wilschut J; Daemen T
    Vaccine; 2005 Jan; 23(10):1232-41. PubMed ID: 15652665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes.
    Kim HS; Park YS
    Cancer Gene Ther; 2002 Feb; 9(2):173-7. PubMed ID: 11857035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.